Chiasma Inc (NASDAQ:CHMA)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - CHMA
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - CHMA
- Market Cap$228.330m
- SymbolNASDAQ:CHMA
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS16706W1027
Company Profile
Chiasma Inc is a biopharmaceutical company that focuses on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases. Its product candidate includes octreotide capsule which has completed Phase III clinical trial and it is being developed for the potential treatment of acromegaly, a rare, debilitating disease. The company offers its products in the United States and the European Union.Chiasma Inc is a biopharmaceutical company which focuses on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases.
Latest CHMA news
Currently there for this company. Visit our news hub for other news .